A fragment of Calpain-1 cleaved α-Synuclein quantified in serum is upregulated in patients with Parkinson’s disease
Abstract Parkinson’s disease (PD) is a progressive neurodegenerative condition. One of the unmet medical needs in PD, are tools for better diagnosis, prognosis, and efficacy of treatment, which reflects the disease course of the individual patient. Alpha-Synuclein (α-Synuclein) is a hallmark of synu...
Saved in:
| Main Authors: | Signe Holm Nielsen, Cecilie Møller Hausgaard, Meryem Benmarce, Morten Karsdal, Kim Henriksen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-92726-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toward alpha‐synuclein seed amplification assay in clinical practice
by: Mathieu Verdurand, et al.
Published: (2025-01-01) -
Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
by: Inga Petersen, et al.
Published: (2023-12-01) -
Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-11-01) -
A splice‐switching antisense oligonucleotide targeting APP reduces accumulation of α‐synuclein in a mouse model of Parkinson's disease
by: Rijwan U. Ahammad, et al.
Published: (2025-04-01) -
USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells
by: Vignesh Srinivasan, et al.
Published: (2025-02-01)